A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma (Q48153477)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

author name string

B M Cantwell

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

J Carmichael

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

S Ghani

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

21

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

49-52

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide/mesa and encephalopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of ifosfamide in cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Xanthogranulomatous malignant fibrous histiocytoma arising from posterior mediastinum

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

False-positive ketonuria during ifosfamide and mesna therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial of isophosphamide (NSC-109724)--results and side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unexpected toxicity in patients treated with iphosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Avoiding ifosfamide/mesna encephalopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of ifosfamide/mesna associated encephalopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults. A preliminary analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical trial adriamycin (NSC 123127) in advanced sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Encephalopathy associated with ifosphamide/mesna therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of advanced soft-tissue sarcomas in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00262738

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/3124971

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48153477&oldid=2209170165"